Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Antimetabolite

From Wikipedia, the free encyclopedia
Chemical that inhibits the use of a metabolite

2D chemical structural diagrams comparing folic acid and methotrexate
The drugmethotrexate (bottom) is an antimetabolite that interferes with the metabolism offolic acid (top)

Anantimetabolite is a chemical thatinhibits the use of ametabolite, which is another chemical that is part of normalmetabolism.[1] Such substances are often similar in structure to the metabolite that they interfere with, such as theantifolates that interfere with the use offolic acid; thus,competitive inhibition can occur, and the presence of antimetabolites can havetoxic effects on cells, such as haltingcell growth andcell division, so these compounds are used inchemotherapy for cancer.[2]

Function

[edit]

Cancer treatment

[edit]

Antimetabolites can be used incancer treatment,[3] as they interfere with DNA production and therefore cell division and tumor growth. Because cancer cells spend more time dividing than other cells, inhibiting cell division harms tumor cells more than other cells. Antimetabolite drugs are commonly used to treat leukemia, cancers of the breast, ovary, and the gastrointestinal tract, as well as other types of cancers.[4] In theAnatomical Therapeutic Chemical Classification System antimetabolite cancer drugs are classified under L01B.

Antimetabolites generally impair DNA replication machinery, either by incorporation of chemically altered nucleotides or by depleting the supply of deoxynucleotides needed for DNA replication and cell proliferation.

Examples of cancer drug antimetabolites include, but are not limited to the following:

Anti-metabolites masquerade as apurine (azathioprine,mercaptopurine) or apyrimidine, chemicals that become the building-blocks of DNA. They prevent these substances from becoming incorporated into DNA during theS phase (of thecell cycle), stopping normal development and cell division.[6] Anti-metabolites also affect RNA synthesis. However, becausethymidine is used in DNA but not in RNA (whereuracil is used instead), inhibition of thymidine synthesis viathymidylate synthase selectively inhibits DNA synthesis over RNA synthesis.

Due to their efficiency, these drugs are the most widely usedcytostatics. Competition for the binding sites ofenzymes that participate in essential biosynthetic processes and subsequent incorporation of these biomolecules intonucleic acids, inhibits their normal tumor cell function and triggersapoptosis, the cell death process. Because of this mode of action, most antimetabolites have high cell cycle specificity and can target arrest of cancer cell DNA replication.[7]

Anthracyclines are anti-tumor antibiotics that interfere with enzymes involved in copying DNA during thecell cycle.[4] These represent an alternative mode of cancer treatment, blocking tumour growth through non-mimetic mechanisms such as DNA intercalation or inducing damage to nucleic acids.

Examples of anthracyclines include:

Anti-tumor antibiotics that are not anthracyclines include:[4]

Anti-bacterial antimetabolites

[edit]

Some antimetabolites can also beantibiotics, such assulfanilamide drugs, which inhibitdihydrofolate synthesis in bacteria by competing withpara-aminobenzoic acid (PABA).[9] PABA is needed in enzymatic reactions that produce folic acid, which acts as a coenzyme in the synthesis of purines and pyrimidines, the building-blocks of DNA. Mammals do not synthesize their own folic acid so they are unaffected by PABA inhibitors, which selectively kill bacteria.

Other uses

[edit]

Antimetabolites, particularlymitomycin C (MMC), are commonly used in America and Japan as an addition totrabeculectomy, a surgical procedure to treatglaucoma.[10]

Antimetabolites have been shown to decreasefibrosis of operative sites. Thus, its use following externaldacryocystorhinostomy, a procedure for the management ofnasolacrimal duct obstruction, is being researched.[11]

Intraoperative antimetabolite application, namelymitomycin C (MMC) and5-fluorouracil (5-FU), is currently being tested for its effectiveness of managingpterygium.[12]

Types

[edit]

Main categories of these drugs include:[13][14]

  • base analogues (alterednucleobases) – structures that can substitute for a normalnucleobases innucleic acids. This means that these molecules are structurally similar enough to the basic components of DNA that they can be substituted in. However, since they are slightly different from the normal bases after they are incorporated into the DNA, the DNA production is halted and the cell dies.
  • nucleoside analoguesnucleoside alternatives that consist of anucleic acid analogue and asugar. This means these are the same bases as above, but with an added sugar group. For the nucleoside analogues either the base or the sugar component can be altered. They are similar enough to the molecules used to build cellular DNA that they are incorporated by the cell into its DNA, but different enough that after being added the cell's DNA they stop cell growth.
  • nucleotide analoguesnucleotides alternatives that consist of anucleic acid, asugar, and 1–3phosphates. This means these molecules look exactly like the pieces used to build DNA in a cell and can be incorporated into a growing cell's DNA. However, because they are analogues and therefore slightly different from regular nucleotides, causing the cell's growth to be halted and the cell to die.
  • antifolates – chemicals that block the actions offolic acid (vitamin B9) which is needed to build DNA and allow cells to grow.

Nucleobases, nucleotides, and nucleosides

See also

[edit]

References

[edit]
  1. ^Smith AL (1997).Oxford dictionary of biochemistry and molecular biology. Oxford [Oxfordshire]: Oxford University Press. p. 43.ISBN 978-0-19-854768-6.
  2. ^Peters GJ, van der Wilt CL, van Moorsel CJ, Kroep JR, Bergman AM, Ackland SP (2000). "Basis for effective combination cancer chemotherapy with antimetabolites".Pharmacology & Therapeutics.87 (2–3):227–253.doi:10.1016/S0163-7258(00)00086-3.PMID 11008002.
  3. ^Antineoplastic+Antimetabolites at the U.S. National Library of MedicineMedical Subject Headings (MeSH)
  4. ^abc"How Chemotherapy Drugs Work". American Cancer Society.
  5. ^abMatera C, Gomila AM, Camarero N, Libergoli M, Soler C, Gorostiza P (November 2018). "Photoswitchable Antimetabolite for Targeted Photoactivated Chemotherapy".Journal of the American Chemical Society.140 (46):15764–15773.doi:10.1021/jacs.8b08249.hdl:2445/126377.PMID 30346152.S2CID 53043366.
  6. ^Takimoto CH, Calvo E."Principles of Oncologic Pharmacotherapy"Archived 2020-05-03 at theWayback Machine in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds)Cancer Management: A Multidisciplinary ApproachArchived 2013-10-04 at theWayback Machine. 11 ed. 2008.
  7. ^Avendano C, Menendez CJ (2015).Medicinal Chemistry of Anticancer Drugs (2nd ed.). Elsevier Science.
  8. ^Mashita T, Kowada T, Takahashi H, Matsui T, Mizukami S (June 2019). "Light-Wavelength-Based Quantitative Control of Dihydrofolate Reductase Activity by Using a Photochromic Isostere of an Inhibitor".ChemBioChem.20 (11):1382–1386.doi:10.1002/cbic.201800816.PMID 30656808.S2CID 58567138.
  9. ^Silverman RB (2004).The Organic Chemistry of Drug Design and Drug Action (2nd ed.).
  10. ^Siriwardena D, Edmunds B, Wormald RP, Khaw PT (July 2004)."National survey of antimetabolite use in glaucoma surgery in the United Kingdom".The British Journal of Ophthalmology.88 (7):873–876.doi:10.1136/bjo.2003.034256.PMC 1772249.PMID 15205228.
  11. ^Gage-White L, LaMear WR, Paleri V, Robson A, Bearn (August 1, 2003)."Surgical Approaches and Antimetabolite Use in Dacryocystorhinostomy: A Meta-Analysis".Otolaryngology–Head and Neck Surgery.129 (2): P205.doi:10.1016/S0194-5998(03)01253-1.S2CID 72098513.
  12. ^Kareem AA, Farhood QK, Alhammami HA (2012)."The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium".Clinical Ophthalmology.6:1849–1854.doi:10.2147/OPTH.S38388.PMC 3497463.PMID 23152665.
  13. ^Woolley DW (March 1987).A Study of Antimetabolites. New York: John Wiley & Sons, Inc.ISBN 9780471960300.
  14. ^Leumann CJ (April 2002). "DNA analogues: from supramolecular principles to biological properties".Bioorganic & Medicinal Chemistry.10 (4):841–854.doi:10.1016/S0968-0896(01)00348-0.PMID 11836090.

External links

[edit]
SPs/MIs
(M phase)
Blockmicrotubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDT
Other
Enzyme inhibitors
Receptor antagonists
Other/ungrouped
Authority control databases: NationalEdit this at Wikidata
Retrieved from "https://en.wikipedia.org/w/index.php?title=Antimetabolite&oldid=1333748376"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp